StockTipsArenaBeta

BUY Lupin Limited — Jigar S Patel, Anand Rathi

BUYLupin Limited

byJigar S Patel, Anand RathiHorizon: 1–3 months28 Sept 2026via ET Now

Entry₹2,060.9Inferred
Target₹2,300
Total upside +11.60%
Stop loss₹2,000-2.96% risk
CMP₹2,0629h ago
Active+0.05%+11.54%upside left 3 mo left
Follow Jigar S Patel for new calls(24% target hit, 33 closed calls)Get alertsWatch LUPIN for new buy/sell callsGet alertsSee 5 other Short-term calls on LUPINSee 28 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Sept, 1:50 am IST
9 supporting1 opposing
Supports the BUY call (9)

MACD above its signal line — bullish momentum

Technicals · macd·28 Sept · today

Lupin Ltd has received tentative approval from the U.S. FDA for its Apixaban oral suspension, a generic version of a drug used to reduce the risk of stroke and blood clots.

BSE · Company Update·28 Sept · today

(opens in new tab)

Lupin share price is currently 'overemphasizing' a risk while 'undermining' a positive, HSBC says

NewsCnbc-Tv18·22 Sept · 6d ago

(opens in new tab)

8 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·22 Sept · 6d ago

5 other SEBI-registered advisors have active short-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · same horizon·22 Sept · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·27 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.